• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长非编码 RNA 作为非小细胞肺癌的潜在生物标志物:目前我们了解多少?

Long non-coding RNA as potential biomarkers in non-small-cell lung cancer: What do we know so far?

机构信息

Department of Biochemistry and Molecular Biology, Poznań University of Medical Sciences, Poznań, Poland.

Department of Biochemistry and Molecular Biology, Poznań University of Medical Sciences, Poznań, Poland.

出版信息

Biomed Pharmacother. 2018 May;101:322-333. doi: 10.1016/j.biopha.2018.02.099. Epub 2018 Mar 22.

DOI:10.1016/j.biopha.2018.02.099
PMID:29499406
Abstract

Non-small-cell lung cancer (NSCLC) remains one of the most frequent types of lung cancer characterized by its local advancement at diagnosis. Therefore, identification of new prognostic biomarkers has become one of the most important issue in NSCLC therapy. It is now well understood that genetic and epigenetic alterations are responsible for NSCLC development. Moreover, it has been recently revealed that the non-protein coding regions of the genome may serve as a template for transcription of various type of RNAs, collectively referred to as non-coding RNAs. Non-coding RNAs, including long non-coding RNAs (lncRNAs) are involved in multiple cellular processes and it has been suggested that aberrant expression of lncRNAs may lead to tumour development, including NSCLC. Furthermore, some of the established risk factors for NSCLC may have an impact on expression level of several types of lncRNAs, and thus, affect the lung carcinogenesis through lncRNAs regulation. In this review, we would like to summarise the to-date knowledge about lncRNAs as potential biomarkers in NSCLC and the role of various environmental factors, such as smoking and air pollution, in development and progression of this tumour and their effect on lncRNAs expression.

摘要

非小细胞肺癌(NSCLC)仍然是最常见的肺癌类型之一,其特征是在诊断时局部进展。因此,寻找新的预后生物标志物已成为 NSCLC 治疗的最重要问题之一。现在已经清楚的是,遗传和表观遗传改变是导致 NSCLC 发展的原因。此外,最近已经揭示,基因组的非蛋白编码区域可以作为各种类型 RNA 转录的模板,统称为非编码 RNA。非编码 RNA,包括长非编码 RNA(lncRNA),参与多种细胞过程,据推测,lncRNA 的异常表达可能导致肿瘤的发生,包括 NSCLC。此外,一些已确定的 NSCLC 风险因素可能会影响几种类型 lncRNA 的表达水平,从而通过 lncRNA 调节影响肺癌的发生。在这篇综述中,我们将总结目前关于 lncRNA 作为 NSCLC 潜在生物标志物的知识,以及各种环境因素(如吸烟和空气污染)在这种肿瘤的发生和发展中的作用,以及它们对 lncRNA 表达的影响。

相似文献

1
Long non-coding RNA as potential biomarkers in non-small-cell lung cancer: What do we know so far?长非编码 RNA 作为非小细胞肺癌的潜在生物标志物:目前我们了解多少?
Biomed Pharmacother. 2018 May;101:322-333. doi: 10.1016/j.biopha.2018.02.099. Epub 2018 Mar 22.
2
Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.长链非编码RNA:非小细胞肺癌生物学、诊断与治疗的新见解
Med Oncol. 2016 Feb;33(2):18. doi: 10.1007/s12032-016-0731-2. Epub 2016 Jan 19.
3
RNA-Seq analysis of non-small cell lung cancer in female never-smokers reveals candidate cancer-associated long non-coding RNAs.对从不吸烟女性非小细胞肺癌的RNA测序分析揭示了候选癌症相关长链非编码RNA。
Pathol Res Pract. 2016 Jun;212(6):549-54. doi: 10.1016/j.prp.2016.03.006. Epub 2016 Mar 19.
4
The prognostic value of long non coding RNAs in non small cell lung cancer: A meta-analysis.长链非编码RNA在非小细胞肺癌中的预后价值:一项荟萃分析。
Oncotarget. 2016 Dec 6;7(49):81292-81304. doi: 10.18632/oncotarget.13223.
5
Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas.鉴定和验证人非小细胞肺癌中的长非编码 RNA 标志物。
J Thorac Oncol. 2015 Apr;10(4):645-54. doi: 10.1097/JTO.0000000000000470.
6
Long non-coding RNAs: How to regulate the metastasis of non-small-cell lung cancer.长非编码 RNA:如何调控非小细胞肺癌的转移。
J Cell Mol Med. 2020 Mar;24(6):3282-3291. doi: 10.1111/jcmm.15054. Epub 2020 Feb 12.
7
Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.循环长链非编码RNA在非小细胞肺癌中的诊断和预后潜力
Cell Physiol Biochem. 2018;49(2):816-827. doi: 10.1159/000493043. Epub 2018 Aug 30.
8
New insights into long non-coding RNAs in non-small cell lung cancer.长非编码 RNA 在非小细胞肺癌中的新认识。
Biomed Pharmacother. 2020 Nov;131:110775. doi: 10.1016/j.biopha.2020.110775. Epub 2020 Sep 26.
9
Long noncoding RNAs in lung cancer: what we know in 2015.2015年我们对肺癌中长链非编码RNA的了解
Clin Transl Oncol. 2016 Jul;18(7):660-5. doi: 10.1007/s12094-015-1448-y. Epub 2015 Dec 17.
10
Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.上调的长链非编码RNA AGAP2-AS1通过与非小细胞肺癌细胞中的EZH2和LSD1相互作用来抑制LATS2和KLF2的表达。
Cell Death Dis. 2016 May 19;7(5):e2225. doi: 10.1038/cddis.2016.126.

引用本文的文献

1
Integrative analyses of single-cell and bulk RNA sequencing to construct the tumor-associated macrophage-related prognostic signature in lung adenocarcinoma.整合单细胞和批量RNA测序分析以构建肺腺癌中肿瘤相关巨噬细胞相关的预后特征
PeerJ. 2025 Sep 1;13:e19920. doi: 10.7717/peerj.19920. eCollection 2025.
2
Broadening horizons: molecular mechanisms and disease implications of endothelial-to-mesenchymal transition.拓展视野:内皮-间充质转化的分子机制及疾病影响
Cell Commun Signal. 2025 Jan 9;23(1):16. doi: 10.1186/s12964-025-02028-y.
3
Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges.
非小细胞肺癌的预后因素和标志物:最新进展和未来挑战。
Genes (Basel). 2023 Oct 4;14(10):1906. doi: 10.3390/genes14101906.
4
Inhibition of LNC EBLN3P Enhances Radiation-Induced Mitochondrial Damage in Lung Cancer Cells by Targeting the Keap1/Nrf2/HO-1 Axis.抑制LNC EBLN3P通过靶向Keap1/Nrf2/HO-1轴增强肺癌细胞中辐射诱导的线粒体损伤。
Biology (Basel). 2023 Sep 4;12(9):1208. doi: 10.3390/biology12091208.
5
LncRNA SNHG1: role in tumorigenesis of multiple human cancers.长链非编码RNA SNHG1:在多种人类癌症肿瘤发生中的作用
Cancer Cell Int. 2023 Sep 8;23(1):198. doi: 10.1186/s12935-023-03018-1.
6
Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer.靶向肿瘤微环境中的免疫细胞类型以克服肺癌对PD-1/PD-L1阻断的耐药性。
Front Pharmacol. 2023 Feb 15;14:1132158. doi: 10.3389/fphar.2023.1132158. eCollection 2023.
7
Hypoxia upregulates the expression of lncRNA H19 in non-small cell lung cancer cells and induces drug resistance.缺氧上调非小细胞肺癌细胞中lncRNA H19的表达并诱导耐药性。
Transl Cancer Res. 2022 Aug;11(8):2876-2886. doi: 10.21037/tcr-22-1812.
8
LncRNA-Dependent Mechanisms of Transforming Growth Factor-β: From Tissue Fibrosis to Cancer Progression.转化生长因子-β的长链非编码RNA依赖性机制:从组织纤维化到癌症进展
Noncoding RNA. 2022 May 25;8(3):36. doi: 10.3390/ncrna8030036.
9
Lnc-ABCA12-8 confers acquired resistance to gefitinib in non-small cell lung cancer by regulating the alternative splicing of fibronectin 1 in the IIICS region.Lnc-ABCA12-8 通过调节 fibronectin 1 在 IIICS 区域的选择性剪接赋予非小细胞肺癌对吉非替尼的获得性耐药。
Cancer Gene Ther. 2022 Nov;29(11):1686-1696. doi: 10.1038/s41417-022-00483-0. Epub 2022 Jun 14.
10
Retracted Article: Long noncoding RNA ANRIL knockdown increases sensitivity of non-small cell lung cancer to cisplatin by regulating the miR-656-3p/SOX4 axis.撤回文章:长链非编码RNA ANRIL敲低通过调控miR-656-3p/SOX4轴增加非小细胞肺癌对顺铂的敏感性。
RSC Adv. 2019 Nov 26;9(66):38735-38744. doi: 10.1039/c9ra06993c. eCollection 2019 Nov 25.